These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20308615

  • 1. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G, Fassett J, Tao Y, Zhang P, dos Remedios C, Pritzker M, Hall JL, Garry DJ, Chen Y.
    Circulation; 2010 Apr 06; 121(13):1474-83. PubMed ID: 20308615
    [Abstract] [Full Text] [Related]

  • 2. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
    Gong W, Duan Q, Cai Z, Chen C, Ni L, Yan M, Wang X, Cianflone K, Wang DW.
    Br J Pharmacol; 2013 Dec 06; 170(7):1396-409. PubMed ID: 24032459
    [Abstract] [Full Text] [Related]

  • 3. Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure.
    Chen Y, Traverse JH, Hou M, Li Y, Du R, Bache RJ.
    Am J Physiol Heart Circ Physiol; 2003 May 06; 284(5):H1513-20. PubMed ID: 12679324
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M, Watanabe K, Sato Y, Nakaya M, Kitajima N, Ide T, Inoue R, Kurose H.
    J Biol Chem; 2010 Apr 23; 285(17):13244-53. PubMed ID: 20177073
    [Abstract] [Full Text] [Related]

  • 5. Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.
    Zhang M, Takimoto E, Lee DI, Santos CX, Nakamura T, Hsu S, Jiang A, Nagayama T, Bedja D, Yuan Y, Eaton P, Shah AM, Kass DA.
    Circulation; 2012 Aug 21; 126(8):942-51. PubMed ID: 22829024
    [Abstract] [Full Text] [Related]

  • 6. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.
    Farrow KN, Lee KJ, Perez M, Schriewer JM, Wedgwood S, Lakshminrusimha S, Smith CL, Steinhorn RH, Schumacker PT.
    Antioxid Redox Signal; 2012 Aug 01; 17(3):460-70. PubMed ID: 22229392
    [Abstract] [Full Text] [Related]

  • 7. Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.
    Zhang M, Koitabashi N, Nagayama T, Rambaran R, Feng N, Takimoto E, Koenke T, O'Rourke B, Champion HC, Crow MT, Kass DA.
    Cell Signal; 2008 Dec 01; 20(12):2231-6. PubMed ID: 18790048
    [Abstract] [Full Text] [Related]

  • 8. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC.
    Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1236-43. PubMed ID: 19286961
    [Abstract] [Full Text] [Related]

  • 9. cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium.
    Vandeput F, Krall J, Ockaili R, Salloum FN, Florio V, Corbin JD, Francis SH, Kukreja RC, Movsesian MA.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):884-91. PubMed ID: 19546307
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
    Hsu S, Nagayama T, Koitabashi N, Zhang M, Zhou L, Bedja D, Gabrielson KL, Molkentin JD, Kass DA, Takimoto E.
    Cardiovasc Res; 2009 Feb 01; 81(2):301-9. PubMed ID: 19029137
    [Abstract] [Full Text] [Related]

  • 11. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload.
    Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, Li J, Huang Y, Zhang P, Zhao B, Chen Y.
    Antioxid Redox Signal; 2010 Oct 01; 13(7):1011-22. PubMed ID: 20406135
    [Abstract] [Full Text] [Related]

  • 12. Regulation and role of myocyte cyclic GMP-dependent protein kinase-1.
    Kass DA, Takimoto E.
    Proc Natl Acad Sci U S A; 2010 Jun 15; 107(24):E98; author reply E99. PubMed ID: 20498039
    [No Abstract] [Full Text] [Related]

  • 13. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
    Lee DI, Vahebi S, Tocchetti CG, Barouch LA, Solaro RJ, Takimoto E, Kass DA.
    Basic Res Cardiol; 2010 May 15; 105(3):337-47. PubMed ID: 20107996
    [Abstract] [Full Text] [Related]

  • 14. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.
    Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL.
    PLoS One; 2013 May 15; 8(7):e68028. PubMed ID: 23844149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.
    Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn ME, Kass DA.
    J Clin Invest; 2009 Feb 15; 119(2):408-20. PubMed ID: 19127022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction.
    Lu Z, Xu X, Hu X, Zhu G, Zhang P, van Deel ED, French JP, Fassett JT, Oury TD, Bache RJ, Chen Y.
    Hypertension; 2008 Jan 15; 51(1):19-25. PubMed ID: 17998475
    [Abstract] [Full Text] [Related]

  • 19. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
    Nagayama T, Zhang M, Hsu S, Takimoto E, Kass DA.
    J Pharmacol Exp Ther; 2008 Aug 15; 326(2):380-7. PubMed ID: 18456872
    [Abstract] [Full Text] [Related]

  • 20. Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.
    Blanton RM, Takimoto E, Lane AM, Aronovitz M, Piotrowski R, Karas RH, Kass DA, Mendelsohn ME.
    J Am Heart Assoc; 2012 Oct 15; 1(5):e003731. PubMed ID: 23316302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.